Skip to main content
. 2021 Feb 4;6:6. doi: 10.1038/s41525-021-00172-1

Fig. 1. mPS_colon provides a simple and robust estimation of prognosis for colorectal cancer (CRC) patients.

Fig. 1

a All genes were tested for their potential as prognostic genes with the use of nine independent multicenter data sets. Genes were filtered to identify differentially expressed genes between normal mucosa and CRC tissue with the use of the TCGA-COAD data set, and the identified genes were subjected to a meta-analysis with eight additional cohorts. A machine learning approach (lasso regression) then extracted 16 genes that are important for the prediction of relapse. The robustness of mPS_colon was demonstrated with various CRC subsets. Finally, we found that mPS_colon also estimates the prognosis of individuals with gastric cancer. b mPS_colon distribution in the TCGA-COAD training cohort. c Kaplan–Meier curves of relapse-free survival (RFS) for the GSE39582 CRC test cohort based on mPS_colon. The log-rank P value is shown.